HomeInsightsStock Comparison

Everest Organics Ltd vs J B Chemicals Pharmaceuticals Ltd Stock Comparison

Everest Organics Ltd vs J B Chemicals Pharmaceuticals Ltd Stock Comparison

Last Updated on: Jul 21, 2025

Key Highlights

  • The Latest Trading Price of Everest Organics Ltd is ₹ 335 as of 21 Jul 15:31.
  • The P/E Ratio of Everest Organics Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of J B Chemicals & Pharmaceuticals Ltd changed from 14.4 on March 2020 to 38.3 on March 2025 . This represents a CAGR of 17.71% over 6 years.
  • The Market Cap of Everest Organics Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of J B Chemicals & Pharmaceuticals Ltd changed from ₹ 3928 crore on March 2020 to ₹ 25253 crore on March 2025 . This represents a CAGR of 36.36% over 6 years.
  • The revenue of Everest Organics Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of J B Chemicals & Pharmaceuticals Ltd for the Mar '25 is ₹ 963.96 crore as compare to the Dec '24 revenue of ₹ 971.49 crore. This represent the decline of -0.78%.
  • The ebitda of Everest Organics Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of J B Chemicals & Pharmaceuticals Ltd for the Mar '25 is ₹ 240.92 crore as compare to the Dec '24 ebitda of ₹ 262.51 crore. This represent the decline of -8.22%.
  • The net profit of Everest Organics Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of J B Chemicals & Pharmaceuticals Ltd changed from ₹ 142.32 crore to ₹ 145.69 crore over 8 quarters. This represents a CAGR of 1.18% .
  • The Dividend Payout of Everest Organics Ltd changed from 7.34 % on March 2020 to 0 % on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe Dividend Payout of J B Chemicals & Pharmaceuticals Ltd changed from 31.71 % on March 2020 to 36.98 % on March 2025 . This represents a CAGR of 2.60% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Everest Organics Ltd

  • Everest Organics Limited was incorporated at Hyderabad in February, 1993.
  • It was promoted by S K Srihari Raju and S K. Chittiramabhadra Raju.
  • The Company is engaged in manufacturing of Active Pharmaceutical Ingredients and their intermediaries.
  • The Company commenced its commercial operations in the year 1993.
  • It set up a plant at Aroor, Andhra Pradesh to manufacture bulk drugs and formulations.

About J B Chemicals & Pharmaceuticals Ltd

  • J B Chemicals & Pharmaceuticals Limited (JBC) was originally promoted and incorporated in Maharashtra by J B Mody as J B Mody Chemicals & Pharmaceuticals on December 18, 1976.
  • The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceuticals formulations, herbal remedies and Active Pharmaceutical Ingredients (APIs).
  • The company has manufacturing units at Thane, Belapur, Ankleshwar, Panoli and Daman.
  • The bulk drug plant at Panoli and formulation plant at Daman became operational in Apr.'95.
  • Products like metrogyl, rantac (a ranitidine-based formulation), and nicardia (a cardiac care medicine) form a significant part of the company's sales.

Everest Organics Ltd News Hub

News

Everest Organics schedules board meeting

Everest Organics will hold a meeting of the Board of Directors of the Company on 27 May 20...

Read more

22 May 2025 19:46

News

Everest Organics hits the roof after securing KDMF nod for Rabeprazole Sodium API

The Rabeprazole Sodium API is primarily used to treat conditions related to excessive stom...

Read more

18 Feb 2025 15:45

News

Everest Organics to conduct board meeting

Everest Organics will hold a meeting of the Board of Directors of the Company on 11 Februa...

Read more

06 Feb 2025 13:41

News

Everest Organics to hold board meeting

Everest Organics will hold a meeting of the Board of Directors of the Company on 13 Januar...

Read more

09 Jan 2025 09:31

News

Everest Organics EGM scheduled

Everest Organics announced that an Extra Ordinary General Meeting (EGM) of the Company wil...

Read more

17 Dec 2024 17:42

News

Everest Organics spurts as board to mull fund raising on Dec 10

According to the regulatory filing, the board will discuss and approve a proposal to raise...

Read more

09 Dec 2024 11:23

J B Chemicals & Pharmaceuticals Ltd News Hub

News

J B Chemicals & Pharmaceuticals to conduct AGM

J B Chemicals & Pharmaceuticals announced that the Annual General Meeting(AGM) of the comp...

Read more

12 Jul 2025 09:53

News

J B Chemicals & Pharmaceuticals Ltd leads losers in 'A' group

Jyoti CNC Automation Ltd, Karnataka Bank Ltd, Narayana Hrudayalaya Ltd and Home First Fina...

Read more

30 Jun 2025 15:00

News

J B Chemicals & Pharmaceuticals receives USFDA approval for Amitriptyline Hydrochloride Tablets

J B Chemicals & Pharmaceuticals has received approval from United States Food and Drug Adm...

Read more

26 Jun 2025 18:33

News

JB Chemicals receives USFDA approval for Amitriptyline Hydrochloride tablets

The approved dosages'10 mg, 25 mg, 50 mg, 75 mg, 100 mg, and 150 mg'are indicated for the ...

Read more

25 Jun 2025 12:22

News

J B Chemicals receives USFDA approval for Amitriptyline Hydrochloride Tablets

J B Chemicals & Pharmaceuticals has received approval from United States Food and Drug Adm...

Read more

24 Jun 2025 18:31

News

J B Chemicals & Pharmaceuticals allots 85,390 equity shares under ESOS

J B Chemicals & Pharmaceuticals has allotted 85,390 equity shares under ESOS. Consequently...

Read more

11 Jun 2025 18:10

SWOT Analysis Of Everest Organics Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of J B Chemicals & Pharmaceuticals Ltd

Strength

4

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Everest Organics Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for J B Chemicals & Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Everest Organics Ltd and J B Chemicals & Pharmaceuticals Ltd

Which company has a larger market capitalization, Everest Organics Ltd or J B Chemicals & Pharmaceuticals Ltd?

Market cap of Everest Organics Ltd is 324 Cr while Market cap of J B Chemicals & Pharmaceuticals Ltd is 25,778 Cr

What are the key factors driving the stock performance of Everest Organics Ltd and J B Chemicals & Pharmaceuticals Ltd?

The stock performance of Everest Organics Ltd and J B Chemicals & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Everest Organics Ltd and J B Chemicals & Pharmaceuticals Ltd?

As of July 21, 2025, the Everest Organics Ltd stock price is INR ₹334.0. On the other hand, J B Chemicals & Pharmaceuticals Ltd stock price is INR ₹1651.85.

How do dividend payouts of Everest Organics Ltd and J B Chemicals & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Everest Organics Ltd and J B Chemicals & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions